Recommended Products

The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.

Grassley, Wyden Invite Drugmakers to Testify at Pricing Hearing

Leaders of the Senate Finance Committee invited seven leading drug companies to testify in an upcoming hearing on drug pricing — and hinted that they will take a more aggressive approach if the drugmakers decline the invitation.

Committee Chair Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) invited AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi to testify at the Feb. 26 hearing. The letters are invitations rather than subpoenas, but the senators referred to their previous remarks at a Jan. 29 hearing about compelling testimony.

“This is an opportunity for companies that produce life-saving treatments to explain how they price these treatments and whether the status quo is acceptable,” the senators said in a joint statement. “Patients and taxpayers deserve to hear from leaders in the industry about what’s behind this unsustainable trend and what can be done to lower costs.”